LLY Eli Lilly and Company
$1,432.29
Eli Lilly and Company (LLY) Earnings News
Earnings press releases, previews and reviews for Eli Lilly and Company (LLY), newest first. Our most recent is review: Eli Lilly Clears Consensus but Misses the Whisper as a $4.57 IPR&D Charge Masks a Third Straight Guidance Raise.
Thursday
October 29, 2026
3:18 PM ET
Eli Lilly Clears Consensus but Misses the Whisper as a $4.57 IPR&D Charge Masks a Third Straight Guidance Raise
Earnings Whispers · Review
Thursday
October 29, 2026
6:45 AM ET
Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio
Wednesday
October 21, 2026
1:25 PM ET
Lilly's First Full Quarter of Medicare Bridge and Foundeo Ramp Faces a Lofty Whisper
Earnings Whispers · Preview
Thursday
October 15, 2026
10:00 AM ET
Lilly confirms date and conference call for third-quarter 2026 financial results announcement
Monday
October 5, 2026
2:28 PM ET
Nasdaq Hits Fresh Highs While Dow Slips and Small Caps Struggle for Direction
Wednesday
August 12, 2026
9:15 AM ET
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
Wednesday
August 5, 2026
6:45 AM ET
Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress
Wednesday
July 22, 2026
10:00 AM ET
Lilly confirms date and conference call for second-quarter 2026 financial results announcement